52North
Oakham, United Kingdom
Our innovative device helps to rapidly identify chemotherapy patients who are at risk of a life threatening complication called neutropenic sepsis. Neutropenic sepsis prematurely takes tens of thousands of lives each year and costs healthcare systems tens of billions of dollars. Through better triaging, Neutrocheck has the potential to save thousands of lives, free up valuable healthcare resources, and make patients' lives easier, simpler, and better.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2018
- Website
- 52north.health/
Categories
Disease Areas
Technologies
Only accessible to MedStartr community members.
Join nowWhat do you think of 52North?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now